XRHealth, a provider of AI-powered Extended Reality (XR) solutions for therapeutic workflows and clinical services, has acquired RealizedCare, a leader in immersive digital therapeutics, for an undisclosed amount. RealizedCare specializes in developing evidence-based, clinically validated digital therapeutics designed to address mental wellness and a spectrum of mental and behavioral conditions. Their integrated platform focuses on simplifying the patient experience, enabling clinician oversight, and generating measurable outcomes. XRHealth empowers clinicians and transforms patients' lives worldwide through its cutting-edge XR technology, offering treatment in areas such as pain management, mental health, and cognitive therapy.
This acquisition is a strategic move designed to significantly enhance XRHealth's platform and expand its capabilities. RealizedCare's expertise in evidence-based, immersive digital therapeutics for mental health directly aligns with XRHealth's mission to revolutionize therapy. The integration of RealizedCare's clinically validated methods will strengthen XRHealth's offerings, particularly in managing chronic pain, stress, and anxiety, and is expected to further advance XRHealth's AI-driven, value-based care solutions.
The combination of both entities creates a larger and more comprehensive AI-driven therapeutic XR platform. RealizedCare's suite of mental wellness and behavioral condition treatments will enrich XRHealth's existing range of immersive therapies across physical and mental health. Synergies are anticipated in delivering an enhanced, integrated platform that provides greater access to treatments, streamlines the patient experience, and supports more effective clinician oversight with patient-specific care plans and measurable outcomes, leveraging a combined team of clinicians, researchers, and technology innovators.
Looking ahead, the unified organization is positioned to accelerate innovation in the digital therapeutics space. This acquisition solidifies XRHealth's commitment to improving access to better mental health and a broader spectrum of immersive, evidence-based care through advanced extended reality technology, reinforcing its leadership in the global therapeutic XR market.